Ernexa Therapeutics Inc. Equity Method Investment, Ownership Percentage
Ernexa Therapeutics Inc. (ERNA) had Equity Method Investment, Ownership Percentage of 51.00% as of 2019-12-31, per its 10-K filed 2020-03-19.
Discontinued › Notes › Investments
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2020-03-19
- 2019-12-31: Equity Method Investment, Ownership Percentage 51.00%.
- 2019-09-30: Equity Method Investment, Ownership Percentage 51.00%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2019-12-31 | 51.00% 10-K · filed 2020-03-19 |
| 2019-09-30 | 51.00% 10-Q · filed 2019-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |